These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29739533)

  • 1. Risks: Absolute or Relative-What should I care about?
    Thromb Res; 2018 May; 165():116. PubMed ID: 29739533
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative vs absolute risk and odds: Understanding the difference.
    Jiroutek MR; Turner JR
    J Clin Hypertens (Greenwich); 2019 Jun; 21(6):859-861. PubMed ID: 31020779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Information is more than just the number].
    Timmermans DR
    Ned Tijdschr Geneeskd; 2016; 160():D825. PubMed ID: 27552940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The number needed to treat (NNT) and the number needed to harm (NNH)].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Mar; 38(3):103-6. PubMed ID: 26364396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of numbers needed to treat should be based on absolute risks.
    Bender R; Kromp M; Kiefer C; Sturtz S
    J Clin Epidemiol; 2014 Feb; 67(2):238-9. PubMed ID: 24183605
    [No Abstract]   [Full Text] [Related]  

  • 6. Numbers needed to treat and to harm should be included in research.
    Hawkins J
    BMJ; 2017 Mar; 356():j1265. PubMed ID: 28283495
    [No Abstract]   [Full Text] [Related]  

  • 7. Number needed to treat.
    Gilmore S
    Australas J Dermatol; 2012 Aug; 53(3):240. PubMed ID: 22881469
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure rate: Why many cancer drugs don't receive FDA approval, and what can be done about it.
    Printz C
    Cancer; 2015 May; 121(10):1529-30. PubMed ID: 25946212
    [No Abstract]   [Full Text] [Related]  

  • 9. Number needed to treat from absolute risk and incidence rate: how to make apples and oranges comparable?
    Girerd N; Rabilloud M; Duarte K; Roy P
    J Clin Epidemiol; 2014 Feb; 67(2):236-8. PubMed ID: 24210846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Number needed to treat (NNT), an index for clinical therapeutic efficacy assessment--its significance and application].
    Cao HJ; Liu JP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):752-6. PubMed ID: 20929138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number needed to treat: a useful statistic to evaluate the impact of an intervention.
    Perez-Padilla R; Patino CM; Ferreira JC
    J Bras Pneumol; 2019 Dec; 45(6):e20190371. PubMed ID: 31826107
    [No Abstract]   [Full Text] [Related]  

  • 12. Introducing Medicine by the Numbers: A Collaboration of The NNT Group and AFP.
    Siwek J; Newman DH
    Am Fam Physician; 2015 Apr; 91(7):434-5. PubMed ID: 25884739
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistics commentary series: commentary #4--relative risk and the number needed to treat.
    Streiner DL
    J Clin Psychopharmacol; 2014 Oct; 34(5):549-51. PubMed ID: 25119252
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actions.
    Chapelle N; Martel M; Barkun AN; Bardou M
    Gut; 2022 Jun; 71(6):1045-1046. PubMed ID: 33811040
    [No Abstract]   [Full Text] [Related]  

  • 15. Number needed to treat and number needed to harm: What are they good for?
    Citrome L
    Eur Neuropsychopharmacol; 2023 Mar; 68():105-107. PubMed ID: 36709515
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019.
    Elliott MH; Skydel JJ; Dhruva SS; Ross JS; Wallach JD
    JAMA Intern Med; 2021 Feb; 181(2):282-284. PubMed ID: 33226398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA
    Int J Clin Pract; 2013 May; 67(5):407-11. PubMed ID: 23574101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From evidence-based medicine to personalized medicine, with particular emphasis on drug-safety monitoring.
    Ennezat PV; Cosgrove S; Bouvaist H; Maréchaux S; Guerbaai RA; Le Jemtel T; Andréjak M; Vital-Durand D
    Arch Cardiovasc Dis; 2017; 110(6-7):413-419. PubMed ID: 28552224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numbers needed to treat (lives!) and numbers needed to save (money).
    Ribichini F; Taggart D; Vassanelli C
    EuroIntervention; 2013 Jun; 9(2):175-7. PubMed ID: 23793004
    [No Abstract]   [Full Text] [Related]  

  • 20. [How I explore ... a risk difference in the occurrence of an event in clinical trials].
    Scheen AJ; Ernest P; Jandrain B
    Rev Med Liege; 2012 Nov; 67(11):597-602. PubMed ID: 23346831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.